The "Chromotouch Chromosome SNP Microarray Optima Products of Conception (POC) Test" offered by DNA Labs UAE is a sophisticated diagnostic tool designed to analyze genetic material from products of conception. This test employs cutting-edge SNP (Single Nucleotide Polymorphism) microarray technology to detect chromosomal abnormalities that may have contributed to miscarriage or fetal loss. By examining the genetic makeup of the POC, the test can identify various types of genetic disorders, including aneuploidies, microdeletions, and duplications, providing crucial information for understanding the cause of pregnancy loss.
The cost of the Chromotouch Chromosome SNP Microarray Optima POC Test is set at 3510 AED, reflecting the advanced technology and comprehensive analysis it entails. Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers invaluable insights for couples facing recurrent pregnancy losses, guiding them towards appropriate genetic counseling and future pregnancy planning. The results from this test can help healthcare providers offer targeted advice and support, potentially improving the chances of a successful pregnancy in the future.
The FISH-NTRK 1, 2, and 3 Gene Panel Test is a specialized diagnostic assay performed at DNA Labs UAE, designed to detect rearrangements within the NTRK1, NTRK2, and NTRK3 genes. These genes encode for the neurotrophic tyrosine receptor kinase proteins, which are key players in the development and function of the nervous system. Alterations in these genes can lead to the production of oncogenic fusion proteins, contributing to the development of various types of cancers, including lung, thyroid, and colorectal cancers.
Fluorescence in situ hybridization (FISH) is the technique utilized in this test, offering a highly sensitive and specific method for identifying genetic abnormalities. This approach allows for the direct visualization of gene rearrangements on the chromosomes, providing clinicians with critical information that can influence treatment decisions, particularly the use of TRK inhibitors in targeted cancer therapy.
The test is priced at 3510 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic diagnostics. The cost reflects the comprehensive nature of the analysis, covering the detection of rearrangements in all three NTRK genes, which is essential for a thorough evaluation and accurate diagnosis. Patients and healthcare providers considering this test can expect reliable results that play a crucial role in personalized medicine, particularly in the context of cancer treatment.
Myeloproliferative Neoplasia with Eosinophilia Test is a specialized diagnostic procedure aimed at detecting genetic abnormalities associated with myeloproliferative disorders that are characterized by an excessive production of eosinophils, a type of white blood cell. These disorders are a subset of myeloproliferative neoplasms (MPNs), which are blood cancers that occur when the body makes too many white or red blood cells, or platelets. Eosinophilia can lead to various health complications, including damage to the heart, lungs, and other organs due to the accumulation of eosinophils.
The test typically focuses on identifying specific gene mutations or rearrangements that are known to be associated with these disorders, such as the FIP1L1-PDGFRA fusion gene, which is common in patients with chronic eosinophilic leukemia (CEL). By detecting these genetic markers, healthcare providers can confirm a diagnosis of myeloproliferative neoplasia with eosinophilia, which is crucial for determining the most effective treatment plan.
In the United Arab Emirates, this test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services. The cost of the Myeloproliferative Neoplasia with Eosinophilia Test at DNA Labs UAE is 3860 AED. This test is instrumental in guiding the clinical management of patients, helping to tailor therapies that target the specific genetic alterations driving the disease, thereby improving patient outcomes.
The Thrombophilia Comprehensive Profile Test is a specialized diagnostic evaluation designed to identify genetic predispositions or acquired conditions that increase an individual's risk of developing abnormal blood clots. This comprehensive assessment is crucial for individuals with a personal or family history of thrombosis, as it aids in the identification of underlying clotting disorders. By analyzing various genetic markers and blood clotting factors, this test provides essential insights into the patient's thrombotic risk, enabling personalized management and prevention strategies.
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test ensures accuracy and reliability in results. With a cost of 3860 AED, the Thrombophilia Comprehensive Profile Test is a valuable investment for those seeking to understand their risk factors for thrombosis and to take proactive steps in managing their health. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality controls, offering patients and healthcare providers confidence in the test outcomes and recommendations for care.
The "HLA Pre-Transplant Workup Sensitized Recipient Panel 4 Test" is a critical diagnostic procedure conducted before organ transplantation to ensure compatibility between the donor and the recipient. This test is particularly essential for recipients who are considered sensitized, meaning they have developed antibodies against potential donor HLA (Human Leukocyte Antigen) types due to previous transplants, blood transfusions, or pregnancies. The presence of these antibodies can significantly increase the risk of transplant rejection.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test meticulously analyzes the recipient's blood for specific HLA antibodies that could react against the donor's organ. By identifying these antibodies, healthcare providers can make informed decisions on the suitability of a potential donor, thereby increasing the chances of transplant success and longevity of the transplanted organ.
The cost of the "HLA Pre-Transplant Workup Sensitized Recipient Panel 4 Test" at DNA Labs UAE is 3860 AED. This investment is crucial for sensitized recipients, as it provides a detailed risk assessment that guides the transplant team in selecting the most compatible donor, ultimately contributing to a better outcome for the recipient.
The "Cultured AFB Drug Resistant DR Mycobacterium Anti-Tubercular DST Rapid 15 Drugs Panel Test" is a comprehensive diagnostic tool used for the detection of drug-resistant strains of Mycobacterium tuberculosis, the bacteria responsible for tuberculosis (TB). This test is particularly vital in tailoring the most effective treatment plan for TB patients, especially in cases where the bacteria have developed resistance to conventional anti-tubercular drugs.
Performed at DNA Labs UAE, this test evaluates the bacteria's resistance to a panel of 15 different anti-tubercular drugs, providing a rapid and detailed profile of drug susceptibility. This information is crucial for clinicians to devise an appropriate and effective treatment regimen, significantly improving patient outcomes.
The cost of the test is 3810 AED, which reflects the comprehensive nature of the analysis and the sophisticated technology employed to ensure accurate and swift results. By identifying drug-resistant strains early, this test plays a critical role in combating the spread of tuberculosis, especially in regions where the disease is prevalent and strains are increasingly resistant to standard treatments.
The Glioma Prognostic Panel Test is a cutting-edge diagnostic tool designed to provide vital information about gliomas, which are a type of tumor that occurs in the brain and spinal cord. By analyzing specific genetic markers within the tumor's DNA, this test can offer insights into the tumor's type, aggressiveness, and potential response to various treatments. This information is crucial for tailoring the most effective treatment plan for each individual patient, potentially improving outcomes and survival rates.
The test cost is set at 3740 AED and is available at DNA Labs UAE, a leading facility in genetic testing and analysis. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic diagnostics, ensuring that patients receive accurate and reliable results. By opting for the Glioma Prognostic Panel Test at DNA Labs UAE, patients and their healthcare providers can make informed decisions regarding the management of gliomas, based on a comprehensive understanding of the tumor's genetic profile.
The Lung Cancer Mutation Panel Test is a sophisticated diagnostic tool designed to identify specific genetic mutations associated with lung cancer. This comprehensive test analyzes a panel of genes known to be involved in the development and progression of lung cancer, helping healthcare professionals to tailor treatment strategies based on the genetic makeup of the tumor. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a critical insight into the molecular underpinnings of an individual's cancer, enabling personalized medicine approaches that can significantly improve treatment outcomes.
Priced at 3740 AED, the test represents an investment in a patient's health journey, offering a detailed understanding of the cancer's characteristics. This information is invaluable for oncologists in selecting the most effective therapies, potentially sparing patients from the side effects of treatments unlikely to be beneficial based on their tumor's genetic profile. The Lung Cancer Mutation Panel Test at DNA Labs UAE stands as a testament to the advances in precision medicine, offering hope and improved care to individuals battling lung cancer.
The Rickettsia Antibody Panel Test is a diagnostic tool used to detect the presence of antibodies against Rickettsia bacteria in the blood. This test is crucial for diagnosing infections caused by Rickettsia, a genus of bacteria that is primarily transmitted to humans through the bites of infected ticks, fleas, and lice. These infections can lead to a range of illnesses, including Rocky Mountain spotted fever, typhus, and scrub typhus, among others. Early detection and treatment are vital for preventing complications associated with these diseases.
The test is performed by collecting a blood sample from the patient, which is then analyzed for the presence of specific antibodies that the body produces in response to a Rickettsia infection. The presence of these antibodies indicates a current or past infection.
In the United Arab Emirates, the Rickettsia Antibody Panel Test is available at DNA Labs UAE, a reputable laboratory known for its advanced diagnostic services. The cost of the test at DNA Labs UAE is 3740 AED. This price reflects the comprehensive nature of the panel, which can detect various strains of Rickettsia, and the specialized techniques used to ensure accurate results. Patients seeking this test can expect professional service and reliable results, aiding in the timely diagnosis and treatment of Rickettsia infections.
Molecular karyotyping for amniotic fluid testing is an advanced genetic examination performed at DNA Labs UAE. This state-of-the-art test is designed to detect chromosomal abnormalities in fetuses by analyzing the amniotic fluid, which surrounds the fetus during pregnancy. The process involves extracting fetal DNA from the amniotic fluid and using molecular karyotyping techniques to identify any genetic disorders or chromosomal abnormalities, such as Down syndrome, Edwards syndrome, or Patau syndrome, among others.
The test offers a high level of accuracy and provides a comprehensive analysis of the chromosomes, going beyond the capabilities of traditional karyotyping methods. It is particularly recommended for pregnancies considered at higher risk for genetic abnormalities. The cost of the molecular karyotyping for amniotic fluid test at DNA Labs UAE is 3740 AED, reflecting the sophisticated technology and expertise involved in conducting this detailed genetic analysis. This test represents a crucial step for expecting parents in understanding and preparing for the health needs of their unborn child.
